Form 8-K - Current report:
SEC Accession No. 0001079973-25-000380
Filing Date
2025-03-13
Accepted
2025-03-13 09:00:08
Documents
16
Period of Report
2025-03-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K scpx_8k.htm   iXBRL 8-K 36810
2 ASSIGNMENT AND ASSUMPTION OF LEASE ex10x1.htm EX-10.1 41337
3 SECOND AMENDMENT TO ASSET AND EQUITY INTERESTS PURCHASE AGREEMENT ex10x2.htm EX-10.2 11320
  Complete submission text file 0001079973-25-000380.txt   339151

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE scpx-20250307.xsd EX-101.SCH 3549
5 XBRL DEFINITION FILE scpx-20250307_def.xml EX-101.DEF 31618
6 XBRL LABEL FILE scpx-20250307_lab.xml EX-101.LAB 37648
7 XBRL PRESENTATION FILE scpx-20250307_pre.xml EX-101.PRE 28229
18 EXTRACTED XBRL INSTANCE DOCUMENT scpx_8k_htm.xml XML 6858
Mailing Address 1305 E. HOUSTON STREET BUILDING 2 SAN ANTONIO TX 78205
Business Address 1305 E. HOUSTON STREET BUILDING 2 SAN ANTONIO TX 78205 919-240-7133
Scorpius Holdings, Inc. (Filer) CIK: 0001476963 (see all company filings)

EIN.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 25733992
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)